BRAF and thyroid nodule: Molecular techniques such as TsV3 enhance the management of thyroid nodules by identifying mutations highly specific for malignancy such as BRAF V600E, RET or TERT, ultimately reducing the number of diagnostic thyroidectomies required [24,31,32,33].